Welcome to the Amylin Pharmaceuticals Q1 2011 Earnings Call. At this time, participants are in a listen-only mode until the question-and-answer session. This conference is being recorded. If you have any objections, please disconnect at this time.
We explore how the Total Return ETF could be different than the mutual fund, what its entrance signals for active ETFs, and what potential investors should bear in mind.